Autologous hematopoietic cell transplantation for adult acute myeloid leukemia: An obsolete or resurfacing concept?

Keyphrases

• Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) 100%
• Adult Acute Lymphoblastic Leukemia 100%
• Acute Myeloid Leukemia 80%
• Hematopoietic Cell Transplantation 40%
• Leukemia Patients 40%
• Treatment-related Mortality 40%
• Graft-versus-host Disease (GvHD) 20%
• Risk Stratification 20%
• Improved Outcomes 20%
• Patient Demographics 20%
• Induction Therapy 20%
• Disease Biology 20%
• Mortality Rate 20%
• Treatment Outcome 20%
• Relapse Risk 20%
• Graft-versus-leukemia Effect 20%
• Post-remission Therapy 20%
• Leukemia Risk 20%
• Complete Remission 20%
• Alternative Donor 20%
• Intermediate Risk 20%
• Minimal Residual Disease 20%
• Autograft 20%
• Scientific Advances 20%
• Relapse Rate 20%
• Leading Causes of Death 20%
• Donor-recipient Matching 20%
• Therapeutic Modalities 20%
• Favorable Risk 20%
• Histocompatibility 20%
• Treatment Intensification 20%
• Transplant Experiment 20%
• Risk Issues 20%
• Clinical Progress 20%

Medicine and Dentistry

• Hematopoietic Cell 100%
• Acute Myeloid Leukemia 100%
• Cell Transplantation 100%
• Disease 14%
• Clinician 14%
• Patient Population 14%
• Risk Stratification 14%
• Chronic Graft Versus Host Disease 14%
• Graft Versus Leukemia Effect 14%
• Autograft 14%
• Mortality Rate 14%
• Alternative Donor 14%
• Recurrence Risk 14%
• Therapeutic Modality 14%
• Minimal Residual Disease 14%
• Histocompatibility 14%